Compare Cemex S.A.B. de C.V. Sponsored ADR (CX) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cemex S.A.B. de C.V. Sponsored ADR vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Cemex S.A.B. de C.V. Sponsored ADR trades at $9.45 (market cap $13.79B), while Halozyme Therapeutics Inc. Common Stock trades at $111.12 (market cap $12.58B). The key difference: Cemex S.A.B. de C.V. Sponsored ADR and Halozyme Therapeutics Inc. Common Stock are close in size by market cap, and Cemex S.A.B. de C.V. Sponsored ADR pays a 1.3% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cemex S.A.B. de C.V. Sponsored ADR for 0 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| CX | HALO | |
|---|---|---|
Market Cap | $13.79B | $12.58B |
Volume | 3,993,982 | 2,179,278 |
Sector | Basic Materials | Health |
52-Week High | $13.55 | $115.22 |
52-Week Low | $9.12 | $61.63 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $19.79B | $14.49B |
Dividend Yield | 1.3% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cemex S.A.B. de C.V. Sponsored ADR
Cemex produces, distributes, markets, and sells cement, ready-mix concrete, aggregates, and other construction materials. Its operations serve markets around the world.
Read more on CX →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
